Navidea Completes Sale of North American Rights of Lymphoseek® to Cardinal Health Mar 3, 2017 03:18PM
Navidea Biopharma (NAVB), Cardinal Health (CAH) Enter Asset Purchase Agreement Nov 23, 2016 03:14PM
Navidea Signs Asset Purchase Agreement with Cardinal Health Nov 23, 2016 03:13PM
Pre-Open Stock Movers 09/16: (DEPO) (INTC) (GPRO) Higher; (NVAX) (DB) (ORCL) Lower (more...) Sep 16, 2016 09:29AM
Navidea Biopharma (NAVB) Enters LOI with ardinal Health for the Sale of Lymphoseek in NA Sep 6, 2016 07:02AM


Sep 6, 2016 06:59AM Navidea Biopharmaceuticals Enters into Letter of Intent with Cardinal Health for the Sale of Lymphoseek® in North America